TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults

Clinical trial NCT00573170 · COMPLETED

Trial details

NCT number: NCT00573170
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Disorders Migraine, Acute

Start date: 2008-02-01
Primary completion: 2009-08-01
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.